Frontier Biotechnologies Inc.
About Frontier Biotechnologies Inc.
Categories
-
CN -
2017On CPHI since
Products from Frontier Biotechnologies Inc. (3)
-
Product Albuvirtide for injection - A Long-acting HIV Fusion Inhibitor
The world’s first long acting HIV fusion inhibitor. An amino acid synthesized peptide, lyophilized powder for injection with shelf life 24 months. The API should be stored and transported at -20C, and the finished product should be stored and transported at 2-8C. ALBUVIRTIDE only need to be ad... -
Product 3BNC117 - A Novel Broad-spectrum HIV Neutralizing Antibody
3BNC117 is one of the most effective broad-spectrum HIV neutralizing antibodies. Several phase 1 and phase 2 clinical trials have been conducted in the US, showing 3BNC117 not only blocks viral replication like other AIDS drugs, but also induces immune response to HIV and HIV-infected cells. Combining 3... -
Product AB001 -A new transdermal patch for musculoskeletal
A third generation topical patch for the management of pain and inflammation. - Long half life; once daily dosage with relatively shorter administration period provides efficacy with less skin irritation/inflammation. - Patch is non-hydrogel, alcohol-free formulation.- Patch matrix formulation is onl...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance